About Firefly Neuroscience
Firefly Neuroscience is a private company based in Kenmore, Kentucky, incorporated in 2022 in Delaware. It has reported $2,758,399 raised in three offerings on Form D since April 2023.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 8, 2026 | Mar 13, 2026 | $2,250,000of $20.2M target | 6 | $375K | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Mar 10, 2023 | Jun 22, 2023 | $375,000of $2.0M target | 6 | $62,500 | EquityRule 506(b) | Form D ↗ |
| Feb 21, 2023 | Apr 6, 2023 | $133,399fully sold | 19 | $7,021 | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $2,758,399 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Firefly Neuroscience's Form D filed Mar 13, 2026.
Earlier filings also listed Jon Olsen (ceo and director, last listed Jun 2023), Stephen Purcell (executive officer, last listed Apr 2023) and Fred Cohen (director, last listed Apr 2023).
Sources
- SECFirefly Neuroscience, Inc. filing history
- CompanyPrivacy policy
- CompanyAbout Firefly Neuroscience
- CompanyLeadership team